These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6778888)

  • 1. Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients.
    Castor CW; Cobel-Geard SR; Hossler PA; Kelch RP
    J Clin Endocrinol Metab; 1981 Jan; 52(1):128-32. PubMed ID: 6778888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
    Castor CW; Miller JW; Walz DA
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue activation. XIII. Stimulation of sulfated glycosaminoglycan synthesis in human connective tissue cells by peptide mediators from lymphocytes and platelets.
    Castor CW; Whitney SL
    J Lab Clin Med; 1978 May; 91(5):811-21. PubMed ID: 641404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator.
    Castor CW; Ritchie JC; Williams CH; Scott ME; Whitney SL; Myers SL; Sloan TB; Anderson BE
    Arthritis Rheum; 1979 Mar; 22(3):260-72. PubMed ID: 420716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor.
    Myers SL; Castor CW
    Arthritis Rheum; 1980 May; 23(5):556-63. PubMed ID: 7378085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
    Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
    Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
    Castor CW; Kotlyar A; Edwards BE
    J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
    Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
    Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera.
    Weiss JJ; Meyers S; Castor CW; Donakowski C; Anderson B
    Clin Chim Acta; 1980 Dec; 108(3):425-33. PubMed ID: 7471473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor.
    Castor CW; Ritchie JC; Scott ME; Whitney SL
    Arthritis Rheum; 1977 Apr; 20(3):859-68. PubMed ID: 856217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue activation XXVI: IgG stimulation of glycosaminoglycan synthesis in human synovial cultures.
    Miller JW; Castor CW
    J Rheumatol; 1983 Apr; 10(2):190-6. PubMed ID: 6408255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
    Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K
    Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue activation. XII. Platelet abnormalities in patients with rheumatoid arthritis.
    Smith AF; Castor CW
    J Rheumatol; 1978; 5(2):177-83. PubMed ID: 671434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue activation. XVI. Detection of a human platelet-derived connective tissue activating peptide (CTAP-III) in human sera and plasma and in synovial fluids and tissues.
    Sloan TB; Weiss JJ; Anderson B; Ritchie JC; Whitney SL; Castor CW
    Proc Soc Exp Biol Med; 1980 Jul; 164(3):267-74. PubMed ID: 6773054
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
    Baeza ML; Reddigari SR; Kornfeld D; Ramani N; Smith EM; Hossler PA; Fischer T; Castor CW; Gorevic PG; Kaplan AP
    J Clin Invest; 1990 May; 85(5):1516-21. PubMed ID: 1692035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue activation. XXX: Isoelectric point microheterogeneity of CTAP-III, a human platelet-derived growth factor.
    Green MS; Hossler PA; Castor CW
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):555-9. PubMed ID: 3081909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of beta-thromboglobulin connective tissue activating peptide-III platelet antigen concentrations in pathologic synovial fluids.
    Myers SL; Christine TA
    J Rheumatol; 1982; 9(1):6-12. PubMed ID: 6177854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.